scispace - formally typeset
D

Diane G. Schwartz

Researcher at State University of New York System

Publications -  32
Citations -  492

Diane G. Schwartz is an academic researcher from State University of New York System. The author has contributed to research in topics: MEDLINE & Health care. The author has an hindex of 12, co-authored 30 publications receiving 438 citations. Previous affiliations of Diane G. Schwartz include Kaleida Health & University at Buffalo.

Papers
More filters
Journal ArticleDOI

Strengthening communication to overcome lateral violence

TL;DR: Ceravolo et al. as mentioned in this paper proposed a quality improvement project to reduce nurse-to-nurse lateral violence and create a more respectful workplace culture through a series of workshops.
Proceedings Article

Barriers, Facilitators, and Solutions to Optimal Patient Portal and Personal Health Record Use: A Systematic Review of the Literature.

TL;DR: Results from the systematic review of the literature should be used to guide the design and implementation of future patient portals and personal health records, and ultimately, close the digital divide.
Journal ArticleDOI

Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology

Stanley A. Schwartz, +1 more
- 03 Jun 1992 - 
TL;DR: This journal aims to publish original contributions and comprehensive reviews related to the understanding and treatment of immune deficiency, allergies, and inflammatory and infectious diseases in children.
Journal ArticleDOI

A leadership challenge: staff nurse perceptions after an organizational TeamSTEPPS initiative.

TL;DR: To measure RNs’ perceptions of teamwork skills and behaviors in their work environment during a multiphase multisite nursing organizational teamwork development initiative, a cross-sectional survey study of bedside RNs was conducted.
Journal ArticleDOI

A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment.

TL;DR: A variety of hypothesized and/or novel treatments are reported to have potential anti-Ebola activity and approaches that utilize multi-targeting/polypharmacology have the most promise in treating EVD.